| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rural Population | 174 | 2025 | 654 | 14.440 |
Why?
|
| HIV Infections | 151 | 2025 | 5097 | 8.500 |
Why?
|
| South Africa | 301 | 2025 | 7596 | 6.200 |
Why?
|
| Humans | 353 | 2025 | 14537 | 5.330 |
Why?
|
| Female | 273 | 2025 | 9103 | 5.310 |
Why?
|
| Adolescent | 158 | 2024 | 2985 | 4.700 |
Why?
|
| Sexual Behavior | 39 | 2024 | 320 | 4.270 |
Why?
|
| Male | 207 | 2025 | 6754 | 4.250 |
Why?
|
| Population Surveillance | 54 | 2024 | 325 | 4.210 |
Why?
|
| Adult | 165 | 2025 | 5913 | 3.740 |
Why?
|
| Cause of Death | 44 | 2025 | 221 | 3.690 |
Why?
|
| Young Adult | 107 | 2024 | 2498 | 3.310 |
Why?
|
| Aged | 95 | 2025 | 1740 | 2.770 |
Why?
|
| Herpes Genitalis | 11 | 2024 | 43 | 2.760 |
Why?
|
| Rural Health | 25 | 2021 | 118 | 2.700 |
Why?
|
| Middle Aged | 111 | 2025 | 3601 | 2.670 |
Why?
|
| Intimate Partner Violence | 10 | 2024 | 55 | 2.550 |
Why?
|
| Sexual Partners | 25 | 2022 | 215 | 2.440 |
Why?
|
| Autopsy | 29 | 2025 | 140 | 2.430 |
Why?
|
| Child | 84 | 2024 | 2242 | 2.360 |
Why?
|
| Health Status | 12 | 2024 | 111 | 2.340 |
Why?
|
| Mortality | 19 | 2021 | 104 | 2.290 |
Why?
|
| Socioeconomic Factors | 42 | 2021 | 411 | 2.270 |
Why?
|
| Cognition | 16 | 2024 | 75 | 2.160 |
Why?
|
| Cross-Sectional Studies | 58 | 2024 | 1422 | 2.110 |
Why?
|
| Longitudinal Studies | 43 | 2024 | 435 | 1.980 |
Why?
|
| Child, Preschool | 68 | 2024 | 1748 | 1.960 |
Why?
|
| Interpersonal Relations | 8 | 2021 | 43 | 1.780 |
Why?
|
| Risk Factors | 56 | 2024 | 1475 | 1.770 |
Why?
|
| Poverty | 17 | 2024 | 152 | 1.640 |
Why?
|
| Adolescent Behavior | 6 | 2024 | 60 | 1.630 |
Why?
|
| Prevalence | 50 | 2024 | 1192 | 1.590 |
Why?
|
| Herpesvirus 2, Human | 10 | 2024 | 43 | 1.590 |
Why?
|
| Exercise | 13 | 2021 | 205 | 1.570 |
Why?
|
| Respiratory Syncytial Virus Infections | 10 | 2024 | 200 | 1.530 |
Why?
|
| Aging | 14 | 2024 | 109 | 1.510 |
Why?
|
| Respiratory Tract Infections | 14 | 2024 | 266 | 1.500 |
Why?
|
| Risk-Taking | 15 | 2021 | 121 | 1.450 |
Why?
|
| Child Mortality | 11 | 2021 | 96 | 1.440 |
Why?
|
| Health Promotion | 9 | 2020 | 109 | 1.420 |
Why?
|
| Infant | 56 | 2024 | 2244 | 1.410 |
Why?
|
| Obesity | 11 | 2024 | 367 | 1.360 |
Why?
|
| Executive Function | 6 | 2023 | 23 | 1.360 |
Why?
|
| Caregivers | 9 | 2025 | 76 | 1.340 |
Why?
|
| Mental Health | 5 | 2024 | 91 | 1.310 |
Why?
|
| Surveys and Questionnaires | 34 | 2024 | 563 | 1.300 |
Why?
|
| Students | 7 | 2023 | 50 | 1.300 |
Why?
|
| Population Dynamics | 7 | 2018 | 27 | 1.290 |
Why?
|
| Qualitative Research | 21 | 2025 | 321 | 1.290 |
Why?
|
| Demography | 19 | 2023 | 105 | 1.290 |
Why?
|
| Incidence | 34 | 2024 | 685 | 1.280 |
Why?
|
| Influenza, Human | 14 | 2023 | 374 | 1.270 |
Why?
|
| Alcohol Drinking | 5 | 2021 | 55 | 1.270 |
Why?
|
| Tuberculosis, Pulmonary | 10 | 2017 | 324 | 1.250 |
Why?
|
| Motivation | 8 | 2020 | 59 | 1.180 |
Why?
|
| Respiratory Syncytial Virus, Human | 8 | 2024 | 155 | 1.180 |
Why?
|
| Social Stigma | 8 | 2024 | 80 | 1.110 |
Why?
|
| Cohort Studies | 28 | 2024 | 967 | 1.100 |
Why?
|
| Community-Based Participatory Research | 7 | 2023 | 24 | 1.100 |
Why?
|
| Patient Acceptance of Health Care | 12 | 2025 | 256 | 1.080 |
Why?
|
| Schools | 7 | 2024 | 73 | 1.080 |
Why?
|
| Aged, 80 and over | 35 | 2025 | 468 | 1.080 |
Why?
|
| Maternal Mortality | 8 | 2015 | 58 | 1.070 |
Why?
|
| Mass Screening | 7 | 2022 | 245 | 1.030 |
Why?
|
| Social Support | 6 | 2021 | 77 | 1.010 |
Why?
|
| Pregnancy | 23 | 2024 | 1862 | 1.000 |
Why?
|
| Infant Mortality | 7 | 2019 | 97 | 1.000 |
Why?
|
| Hypertension | 11 | 2025 | 419 | 0.980 |
Why?
|
| Age Factors | 23 | 2020 | 370 | 0.940 |
Why?
|
| Prospective Studies | 30 | 2024 | 1160 | 0.940 |
Why?
|
| Mental Disorders | 3 | 2023 | 44 | 0.940 |
Why?
|
| Student Dropouts | 5 | 2019 | 8 | 0.930 |
Why?
|
| Parents | 3 | 2023 | 32 | 0.910 |
Why?
|
| Health Behavior | 5 | 2021 | 79 | 0.910 |
Why?
|
| Health Priorities | 5 | 2023 | 62 | 0.890 |
Why?
|
| Infant, Newborn | 28 | 2024 | 1479 | 0.860 |
Why?
|
| Health Education | 2 | 2020 | 35 | 0.860 |
Why?
|
| Primary Health Care | 9 | 2024 | 240 | 0.850 |
Why?
|
| Malnutrition | 4 | 2015 | 56 | 0.820 |
Why?
|
| Residence Characteristics | 8 | 2021 | 57 | 0.800 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2020 | 262 | 0.780 |
Why?
|
| Body Mass Index | 11 | 2021 | 321 | 0.770 |
Why?
|
| Urban Population | 11 | 2021 | 257 | 0.760 |
Why?
|
| Sex Work | 5 | 2020 | 39 | 0.760 |
Why?
|
| Sexual Health | 2 | 2020 | 14 | 0.760 |
Why?
|
| Sex Factors | 17 | 2020 | 227 | 0.750 |
Why?
|
| Violence | 6 | 2023 | 68 | 0.750 |
Why?
|
| Community Participation | 6 | 2023 | 42 | 0.740 |
Why?
|
| Patient Selection | 3 | 2018 | 40 | 0.730 |
Why?
|
| Depression | 5 | 2024 | 121 | 0.730 |
Why?
|
| Social Class | 6 | 2019 | 73 | 0.720 |
Why?
|
| HIV | 10 | 2023 | 380 | 0.720 |
Why?
|
| Vaccines | 1 | 2022 | 86 | 0.720 |
Why?
|
| Preventive Health Services | 1 | 2020 | 17 | 0.710 |
Why?
|
| Anti-Retroviral Agents | 11 | 2021 | 551 | 0.700 |
Why?
|
| Interviews as Topic | 17 | 2024 | 203 | 0.690 |
Why?
|
| Developing Countries | 9 | 2019 | 400 | 0.690 |
Why?
|
| Health Services Accessibility | 11 | 2024 | 280 | 0.680 |
Why?
|
| Hospitalization | 17 | 2023 | 418 | 0.680 |
Why?
|
| Condoms | 4 | 2019 | 88 | 0.670 |
Why?
|
| Self Report | 9 | 2020 | 114 | 0.670 |
Why?
|
| Unsafe Sex | 8 | 2024 | 46 | 0.650 |
Why?
|
| Diabetes Mellitus | 6 | 2025 | 146 | 0.650 |
Why?
|
| Chronic Disease | 6 | 2025 | 107 | 0.650 |
Why?
|
| Community Networks | 6 | 2019 | 13 | 0.640 |
Why?
|
| Self Care | 1 | 2019 | 14 | 0.640 |
Why?
|
| Educational Status | 7 | 2023 | 68 | 0.630 |
Why?
|
| Activities of Daily Living | 6 | 2022 | 41 | 0.630 |
Why?
|
| Pregnancy Rate | 2 | 2015 | 8 | 0.610 |
Why?
|
| Data Collection | 8 | 2014 | 86 | 0.610 |
Why?
|
| Community Health Services | 5 | 2018 | 58 | 0.600 |
Why?
|
| Overweight | 7 | 2019 | 87 | 0.590 |
Why?
|
| Communicable Diseases | 4 | 2023 | 62 | 0.590 |
Why?
|
| Stress, Psychological | 4 | 2024 | 28 | 0.590 |
Why?
|
| Public Assistance | 3 | 2019 | 5 | 0.590 |
Why?
|
| Epidemics | 4 | 2024 | 65 | 0.570 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2015 | 103 | 0.570 |
Why?
|
| Coinfection | 8 | 2016 | 276 | 0.570 |
Why?
|
| Rheumatology | 2 | 2007 | 18 | 0.550 |
Why?
|
| Health Status Disparities | 6 | 2017 | 35 | 0.550 |
Why?
|
| Quality of Health Care | 9 | 2021 | 62 | 0.530 |
Why?
|
| Reproducibility of Results | 11 | 2021 | 217 | 0.530 |
Why?
|
| Pre-Exposure Prophylaxis | 4 | 2024 | 196 | 0.530 |
Why?
|
| Viral Load | 9 | 2024 | 819 | 0.530 |
Why?
|
| Sex Workers | 1 | 2018 | 116 | 0.530 |
Why?
|
| Cardiovascular Diseases | 5 | 2021 | 237 | 0.520 |
Why?
|
| Epilepsy | 4 | 2020 | 17 | 0.520 |
Why?
|
| Truth Disclosure | 2 | 2020 | 18 | 0.510 |
Why?
|
| Family Characteristics | 6 | 2023 | 135 | 0.500 |
Why?
|
| Dementia | 3 | 2024 | 22 | 0.490 |
Why?
|
| Anti-HIV Agents | 8 | 2024 | 1324 | 0.490 |
Why?
|
| Public Health | 5 | 2023 | 124 | 0.490 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2007 | 158 | 0.480 |
Why?
|
| Diarrhea | 6 | 2016 | 76 | 0.480 |
Why?
|
| Health Policy | 6 | 2023 | 140 | 0.480 |
Why?
|
| Sex Distribution | 13 | 2018 | 89 | 0.480 |
Why?
|
| Alcoholism | 3 | 2020 | 17 | 0.470 |
Why?
|
| Acquired Immunodeficiency Syndrome | 7 | 2022 | 187 | 0.460 |
Why?
|
| Research | 4 | 2017 | 65 | 0.450 |
Why?
|
| Virus Diseases | 3 | 2023 | 55 | 0.440 |
Why?
|
| Models, Statistical | 8 | 2017 | 55 | 0.440 |
Why?
|
| Medical Records | 6 | 2006 | 23 | 0.430 |
Why?
|
| Retrospective Studies | 11 | 2023 | 799 | 0.430 |
Why?
|
| Safe Sex | 5 | 2020 | 68 | 0.430 |
Why?
|
| Leadership | 3 | 2024 | 23 | 0.420 |
Why?
|
| Pneumococcal Infections | 4 | 2023 | 299 | 0.410 |
Why?
|
| Public Policy | 4 | 2021 | 24 | 0.410 |
Why?
|
| Blood Pressure | 7 | 2020 | 317 | 0.410 |
Why?
|
| Diet | 4 | 2020 | 109 | 0.400 |
Why?
|
| Logistic Models | 9 | 2024 | 254 | 0.400 |
Why?
|
| Cognitive Dysfunction | 2 | 2025 | 13 | 0.400 |
Why?
|
| Literacy | 4 | 2020 | 9 | 0.400 |
Why?
|
| Resuscitation Orders | 3 | 1997 | 3 | 0.400 |
Why?
|
| United States | 14 | 2020 | 132 | 0.400 |
Why?
|
| Disabled Persons | 3 | 2020 | 23 | 0.400 |
Why?
|
| Life Style | 5 | 2020 | 86 | 0.390 |
Why?
|
| Income | 4 | 2021 | 85 | 0.390 |
Why?
|
| Interrupted Time Series Analysis | 2 | 2025 | 21 | 0.380 |
Why?
|
| Witchcraft | 1 | 2011 | 3 | 0.380 |
Why?
|
| Nutritional Status | 2 | 2013 | 76 | 0.380 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 34 | 0.370 |
Why?
|
| Child Welfare | 2 | 2009 | 16 | 0.370 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2022 | 21 | 0.370 |
Why?
|
| Health Transition | 4 | 2016 | 11 | 0.370 |
Why?
|
| Focus Groups | 8 | 2020 | 196 | 0.370 |
Why?
|
| Microbiota | 2 | 2022 | 30 | 0.370 |
Why?
|
| Adolescent Health | 2 | 2024 | 15 | 0.370 |
Why?
|
| Counseling | 4 | 2023 | 143 | 0.360 |
Why?
|
| Cerebrovascular Disorders | 4 | 1999 | 10 | 0.360 |
Why?
|
| Pneumococcal Vaccines | 4 | 2023 | 278 | 0.360 |
Why?
|
| Streptococcus pneumoniae | 6 | 2023 | 336 | 0.360 |
Why?
|
| Emigration and Immigration | 4 | 2018 | 13 | 0.360 |
Why?
|
| Fertility | 3 | 2013 | 22 | 0.350 |
Why?
|
| Proportional Hazards Models | 6 | 2019 | 163 | 0.350 |
Why?
|
| Self Concept | 3 | 2020 | 13 | 0.350 |
Why?
|
| Friends | 3 | 2019 | 6 | 0.340 |
Why?
|
| Antirheumatic Agents | 2 | 2007 | 35 | 0.340 |
Why?
|
| Metabolic Diseases | 3 | 2018 | 30 | 0.340 |
Why?
|
| Frailty | 2 | 2021 | 15 | 0.340 |
Why?
|
| Quality of Life | 6 | 2017 | 177 | 0.340 |
Why?
|
| Education | 3 | 2018 | 22 | 0.340 |
Why?
|
| Family | 3 | 2025 | 35 | 0.330 |
Why?
|
| Risk Reduction Behavior | 3 | 2019 | 39 | 0.330 |
Why?
|
| Physical Abuse | 2 | 2020 | 8 | 0.330 |
Why?
|
| Severity of Illness Index | 9 | 2021 | 253 | 0.330 |
Why?
|
| Psychometrics | 4 | 2016 | 22 | 0.330 |
Why?
|
| Disease Outbreaks | 7 | 2007 | 111 | 0.320 |
Why?
|
| Linear Models | 6 | 2019 | 83 | 0.320 |
Why?
|
| HIV-1 | 5 | 2021 | 1260 | 0.320 |
Why?
|
| Pandemics | 4 | 2025 | 296 | 0.320 |
Why?
|
| Urban Health | 2 | 2021 | 78 | 0.320 |
Why?
|
| Quality Assurance, Health Care | 2 | 2017 | 43 | 0.310 |
Why?
|
| Feasibility Studies | 3 | 2025 | 101 | 0.310 |
Why?
|
| Registries | 3 | 2016 | 91 | 0.310 |
Why?
|
| Delivery of Health Care | 5 | 2024 | 239 | 0.310 |
Why?
|
| Medicare | 8 | 2020 | 9 | 0.310 |
Why?
|
| Carrier State | 4 | 2023 | 92 | 0.310 |
Why?
|
| Health Services | 3 | 2025 | 51 | 0.300 |
Why?
|
| Genomics | 3 | 2022 | 109 | 0.300 |
Why?
|
| Mothers | 2 | 2024 | 195 | 0.300 |
Why?
|
| Hope | 2 | 2018 | 4 | 0.300 |
Why?
|
| Rural Health Services | 4 | 2017 | 48 | 0.300 |
Why?
|
| Breast Neoplasms | 2 | 2001 | 131 | 0.300 |
Why?
|
| Verbal Behavior | 5 | 2019 | 11 | 0.300 |
Why?
|
| Nasopharynx | 9 | 2023 | 151 | 0.290 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 106 | 0.290 |
Why?
|
| Communication | 3 | 2023 | 57 | 0.290 |
Why?
|
| Cost of Illness | 4 | 2015 | 167 | 0.280 |
Why?
|
| Global Health | 5 | 2017 | 193 | 0.280 |
Why?
|
| Body Height | 3 | 2018 | 52 | 0.280 |
Why?
|
| Pregnancy in Adolescence | 2 | 2019 | 15 | 0.280 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2020 | 472 | 0.280 |
Why?
|
| Viruses | 4 | 2015 | 47 | 0.280 |
Why?
|
| Capacity Building | 2 | 2017 | 32 | 0.280 |
Why?
|
| Eating | 2 | 2017 | 16 | 0.280 |
Why?
|
| Body Image | 2 | 2017 | 17 | 0.280 |
Why?
|
| Pilot Projects | 7 | 2025 | 179 | 0.280 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 34 | 0.270 |
Why?
|
| Adiposity | 2 | 2018 | 96 | 0.270 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2017 | 33 | 0.270 |
Why?
|
| Body Composition | 2 | 2018 | 153 | 0.270 |
Why?
|
| Maternal Health Services | 3 | 2023 | 52 | 0.270 |
Why?
|
| Public Health Surveillance | 5 | 2018 | 52 | 0.270 |
Why?
|
| Health Services Research | 5 | 2023 | 58 | 0.270 |
Why?
|
| Sanitation | 2 | 2023 | 17 | 0.260 |
Why?
|
| Phylogeny | 4 | 2021 | 231 | 0.260 |
Why?
|
| HIV Seropositivity | 4 | 2020 | 265 | 0.260 |
Why?
|
| Multivariate Analysis | 7 | 2015 | 171 | 0.250 |
Why?
|
| African Americans | 2 | 1997 | 47 | 0.250 |
Why?
|
| Acute Disease | 6 | 2017 | 105 | 0.250 |
Why?
|
| Death Certificates | 3 | 2016 | 10 | 0.250 |
Why?
|
| Geography | 4 | 2019 | 60 | 0.250 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 106 | 0.250 |
Why?
|
| Gender Identity | 4 | 2018 | 23 | 0.240 |
Why?
|
| Hospitals, Urban | 3 | 2015 | 23 | 0.240 |
Why?
|
| Frail Elderly | 3 | 2021 | 15 | 0.240 |
Why?
|
| Hospital Mortality | 5 | 2021 | 95 | 0.240 |
Why?
|
| Sentinel Surveillance | 5 | 2017 | 115 | 0.240 |
Why?
|
| Substance-Related Disorders | 2 | 2020 | 51 | 0.240 |
Why?
|
| Pneumonia, Pneumococcal | 3 | 2015 | 100 | 0.240 |
Why?
|
| Research Design | 3 | 2015 | 124 | 0.230 |
Why?
|
| Time Factors | 8 | 2017 | 507 | 0.230 |
Why?
|
| Social Conditions | 2 | 2014 | 10 | 0.230 |
Why?
|
| Feeding Behavior | 2 | 2015 | 60 | 0.230 |
Why?
|
| Health Personnel | 6 | 2022 | 231 | 0.230 |
Why?
|
| Cognitive Aging | 1 | 2024 | 2 | 0.230 |
Why?
|
| Child Custody | 1 | 2024 | 2 | 0.230 |
Why?
|
| Bayes Theorem | 5 | 2013 | 81 | 0.230 |
Why?
|
| Attitude to Health | 4 | 2017 | 56 | 0.230 |
Why?
|
| Anthropometry | 4 | 2018 | 102 | 0.220 |
Why?
|
| Sleep | 2 | 2021 | 36 | 0.220 |
Why?
|
| Health Planning | 2 | 2000 | 13 | 0.220 |
Why?
|
| Population Health | 2 | 2020 | 10 | 0.220 |
Why?
|
| Measles | 1 | 2023 | 36 | 0.220 |
Why?
|
| Rotavirus Infections | 2 | 2014 | 46 | 0.220 |
Why?
|
| Rotavirus Vaccines | 2 | 2014 | 53 | 0.220 |
Why?
|
| Age Distribution | 8 | 2016 | 107 | 0.220 |
Why?
|
| Disease Management | 2 | 2020 | 74 | 0.210 |
Why?
|
| Cluster Analysis | 3 | 2019 | 65 | 0.210 |
Why?
|
| Spatial Analysis | 2 | 2013 | 10 | 0.210 |
Why?
|
| Financial Support | 2 | 2020 | 10 | 0.210 |
Why?
|
| Microphthalmos | 1 | 2022 | 2 | 0.210 |
Why?
|
| Behavior Therapy | 1 | 2022 | 11 | 0.210 |
Why?
|
| Medication Adherence | 3 | 2023 | 151 | 0.210 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 23 | 0.210 |
Why?
|
| Whooping Cough | 1 | 2023 | 36 | 0.200 |
Why?
|
| Social Norms | 1 | 2021 | 8 | 0.200 |
Why?
|
| Water Resources | 1 | 2022 | 3 | 0.200 |
Why?
|
| Program Evaluation | 2 | 2017 | 89 | 0.200 |
Why?
|
| Noncommunicable Diseases | 1 | 2023 | 77 | 0.200 |
Why?
|
| Perception | 3 | 2017 | 42 | 0.190 |
Why?
|
| Sex Characteristics | 1 | 2021 | 43 | 0.190 |
Why?
|
| Tanzania | 3 | 2024 | 88 | 0.190 |
Why?
|
| Spouse Abuse | 2 | 2018 | 12 | 0.190 |
Why?
|
| Comorbidity | 7 | 2019 | 188 | 0.190 |
Why?
|
| Interdisciplinary Placement | 1 | 2021 | 4 | 0.190 |
Why?
|
| Multimorbidity | 1 | 2021 | 42 | 0.190 |
Why?
|
| Physical Therapy Modalities | 2 | 2001 | 7 | 0.190 |
Why?
|
| Arm | 1 | 2001 | 1 | 0.180 |
Why?
|
| Lymphedema | 1 | 2001 | 1 | 0.180 |
Why?
|
| Lymph Node Excision | 1 | 2001 | 2 | 0.180 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 34 | 0.180 |
Why?
|
| Axilla | 1 | 2001 | 3 | 0.180 |
Why?
|
| Housing | 1 | 2021 | 24 | 0.180 |
Why?
|
| Fathers | 1 | 2021 | 9 | 0.180 |
Why?
|
| Life Expectancy | 3 | 2017 | 31 | 0.180 |
Why?
|
| Air Pollution, Indoor | 1 | 2021 | 13 | 0.180 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 55 | 0.180 |
Why?
|
| Health Services Needs and Demand | 2 | 2019 | 57 | 0.180 |
Why?
|
| Sex Offenses | 1 | 2020 | 29 | 0.180 |
Why?
|
| Odds Ratio | 5 | 2021 | 133 | 0.180 |
Why?
|
| Intergenerational Relations | 1 | 2020 | 3 | 0.180 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2020 | 2 | 0.180 |
Why?
|
| Body Weight | 2 | 2011 | 111 | 0.180 |
Why?
|
| Documentation | 2 | 2012 | 3 | 0.180 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 64 | 0.180 |
Why?
|
| Models, Theoretical | 2 | 2017 | 80 | 0.170 |
Why?
|
| Vaccination | 2 | 2020 | 365 | 0.170 |
Why?
|
| Patient Compliance | 2 | 2020 | 120 | 0.170 |
Why?
|
| Risk Assessment | 2 | 2018 | 225 | 0.170 |
Why?
|
| Adolescent Development | 1 | 2020 | 13 | 0.170 |
Why?
|
| Schools, Nursery | 1 | 2019 | 2 | 0.170 |
Why?
|
| Child Care | 1 | 2019 | 5 | 0.170 |
Why?
|
| Sexism | 1 | 2019 | 6 | 0.170 |
Why?
|
| Inpatients | 2 | 2015 | 30 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 69 | 0.170 |
Why?
|
| Probability | 3 | 2020 | 27 | 0.170 |
Why?
|
| World Health Organization | 6 | 2019 | 137 | 0.170 |
Why?
|
| Africa | 6 | 2016 | 376 | 0.170 |
Why?
|
| Internationality | 2 | 2011 | 36 | 0.170 |
Why?
|
| Gender-Based Violence | 1 | 2019 | 12 | 0.170 |
Why?
|
| Case Management | 1 | 2019 | 5 | 0.170 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 17 | 0.170 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 16 | 0.160 |
Why?
|
| Systems Integration | 1 | 2019 | 3 | 0.160 |
Why?
|
| Cross-Cultural Comparison | 1 | 2019 | 16 | 0.160 |
Why?
|
| Social Behavior | 1 | 2019 | 5 | 0.160 |
Why?
|
| Financing, Government | 1 | 2019 | 11 | 0.160 |
Why?
|
| Computer Simulation | 1 | 2019 | 56 | 0.160 |
Why?
|
| Speech | 2 | 2011 | 4 | 0.160 |
Why?
|
| Motor Skills | 1 | 2019 | 6 | 0.160 |
Why?
|
| Primary Prevention | 1 | 2019 | 27 | 0.160 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 26 | 0.160 |
Why?
|
| Epidemiological Monitoring | 2 | 2019 | 45 | 0.160 |
Why?
|
| Self Efficacy | 1 | 2019 | 11 | 0.160 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 385 | 0.160 |
Why?
|
| Kenya | 4 | 2024 | 183 | 0.160 |
Why?
|
| Influenza A virus | 2 | 2016 | 28 | 0.160 |
Why?
|
| Drug Utilization | 1 | 2018 | 10 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 127 | 0.160 |
Why?
|
| Hospitals, Rural | 3 | 2015 | 11 | 0.160 |
Why?
|
| Influenza B virus | 2 | 2016 | 42 | 0.160 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2019 | 108 | 0.160 |
Why?
|
| Nurses | 2 | 2020 | 32 | 0.160 |
Why?
|
| Attitude of Health Personnel | 3 | 2017 | 106 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2019 | 57 | 0.160 |
Why?
|
| Smoking | 1 | 2019 | 100 | 0.160 |
Why?
|
| Genes, pol | 1 | 2018 | 4 | 0.150 |
Why?
|
| Health Equity | 1 | 2018 | 12 | 0.150 |
Why?
|
| Metapneumovirus | 2 | 2016 | 30 | 0.150 |
Why?
|
| Mortality, Premature | 1 | 2018 | 6 | 0.150 |
Why?
|
| Health Resources | 1 | 2019 | 66 | 0.150 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2019 | 56 | 0.150 |
Why?
|
| Cognition Disorders | 1 | 2018 | 36 | 0.150 |
Why?
|
| Commerce | 2 | 2015 | 22 | 0.150 |
Why?
|
| Physical Fitness | 1 | 2018 | 10 | 0.150 |
Why?
|
| Vulnerable Populations | 2 | 2016 | 30 | 0.150 |
Why?
|
| Menarche | 1 | 2018 | 13 | 0.150 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2018 | 2 | 0.150 |
Why?
|
| Leg | 1 | 2018 | 21 | 0.150 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 12 | 0.150 |
Why?
|
| Bias | 1 | 2018 | 15 | 0.150 |
Why?
|
| Social Networking | 1 | 2017 | 8 | 0.150 |
Why?
|
| Hemoglobins | 1 | 2018 | 40 | 0.150 |
Why?
|
| Maternal Death | 2 | 2015 | 25 | 0.150 |
Why?
|
| Immunization Programs | 2 | 2020 | 81 | 0.150 |
Why?
|
| Psychosocial Deprivation | 1 | 2017 | 2 | 0.150 |
Why?
|
| Neoplasms | 2 | 2017 | 147 | 0.140 |
Why?
|
| Pediatric Obesity | 2 | 2015 | 41 | 0.140 |
Why?
|
| Circumcision, Male | 1 | 2018 | 99 | 0.140 |
Why?
|
| Principal Component Analysis | 2 | 2015 | 20 | 0.140 |
Why?
|
| Enterovirus Infections | 1 | 2017 | 10 | 0.140 |
Why?
|
| Enterovirus D, Human | 1 | 2017 | 10 | 0.140 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2007 | 195 | 0.140 |
Why?
|
| AIDS Serodiagnosis | 1 | 2017 | 44 | 0.140 |
Why?
|
| Awareness | 1 | 2017 | 18 | 0.140 |
Why?
|
| Oncologists | 1 | 2017 | 1 | 0.140 |
Why?
|
| Occupational Therapy | 1 | 1997 | 1 | 0.140 |
Why?
|
| Physicians, Primary Care | 1 | 2017 | 4 | 0.140 |
Why?
|
| Aftercare | 1 | 2017 | 10 | 0.140 |
Why?
|
| Transients and Migrants | 3 | 2014 | 39 | 0.140 |
Why?
|
| Bacteremia | 2 | 2014 | 79 | 0.140 |
Why?
|
| Remuneration | 1 | 2016 | 2 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2017 | 54 | 0.140 |
Why?
|
| Birth Certificates | 1 | 2016 | 4 | 0.140 |
Why?
|
| Radiology | 1 | 1996 | 5 | 0.140 |
Why?
|
| Survival Analysis | 4 | 2021 | 149 | 0.140 |
Why?
|
| Drug Resistance, Viral | 1 | 2018 | 278 | 0.140 |
Why?
|
| Radiography, Thoracic | 1 | 1996 | 19 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2017 | 82 | 0.130 |
Why?
|
| Mozambique | 3 | 2013 | 55 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 77 | 0.130 |
Why?
|
| Behavior Rating Scale | 1 | 2016 | 1 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 16 | 0.130 |
Why?
|
| Attitude | 1 | 2016 | 12 | 0.130 |
Why?
|
| Emotional Adjustment | 1 | 2016 | 1 | 0.130 |
Why?
|
| Sapovirus | 1 | 2016 | 6 | 0.130 |
Why?
|
| Bacteriological Techniques | 1 | 2016 | 54 | 0.130 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 11 | 0.130 |
Why?
|
| Hospitals | 5 | 2015 | 103 | 0.130 |
Why?
|
| Resilience, Psychological | 1 | 2016 | 11 | 0.130 |
Why?
|
| Heterosexuality | 1 | 2016 | 30 | 0.130 |
Why?
|
| Social Welfare | 1 | 2015 | 3 | 0.130 |
Why?
|
| Child Development | 1 | 2017 | 93 | 0.130 |
Why?
|
| School Health Services | 1 | 2015 | 19 | 0.130 |
Why?
|
| Social Control, Informal | 1 | 2015 | 5 | 0.130 |
Why?
|
| Alcoholic Beverages | 1 | 2015 | 2 | 0.130 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2015 | 10 | 0.130 |
Why?
|
| Child, Orphaned | 2 | 2015 | 16 | 0.130 |
Why?
|
| Pneumovirus Infections | 1 | 2015 | 7 | 0.120 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 5 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2022 | 244 | 0.120 |
Why?
|
| Health Surveys | 2 | 2019 | 59 | 0.120 |
Why?
|
| Africa South of the Sahara | 4 | 2018 | 353 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2015 | 49 | 0.120 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2015 | 19 | 0.120 |
Why?
|
| Myocardial Infarction | 4 | 1996 | 24 | 0.120 |
Why?
|
| Bronchopneumonia | 1 | 2015 | 11 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 3 | 2006 | 22 | 0.120 |
Why?
|
| Space-Time Clustering | 2 | 2011 | 6 | 0.120 |
Why?
|
| Medicine, African Traditional | 1 | 2014 | 25 | 0.120 |
Why?
|
| Memory Disorders | 2 | 2024 | 4 | 0.120 |
Why?
|
| Disease | 1 | 2014 | 12 | 0.120 |
Why?
|
| Adolescent Health Services | 1 | 2014 | 17 | 0.120 |
Why?
|
| Haemophilus influenzae | 1 | 2014 | 42 | 0.110 |
Why?
|
| Mental Health Services | 1 | 2014 | 10 | 0.110 |
Why?
|
| Tuberculosis | 6 | 2018 | 543 | 0.110 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 43 | 0.110 |
Why?
|
| Kwashiorkor | 2 | 2007 | 4 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 144 | 0.110 |
Why?
|
| Malawi | 2 | 2024 | 87 | 0.110 |
Why?
|
| Token Economy | 1 | 2013 | 1 | 0.110 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 10 | 0.110 |
Why?
|
| Birth Intervals | 1 | 2013 | 3 | 0.110 |
Why?
|
| Absenteeism | 1 | 2013 | 10 | 0.110 |
Why?
|
| Affective Symptoms | 1 | 2013 | 2 | 0.110 |
Why?
|
| Psychology, Child | 1 | 2013 | 3 | 0.110 |
Why?
|
| Sociology, Medical | 1 | 2013 | 2 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2014 | 115 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2015 | 104 | 0.110 |
Why?
|
| Anxiety | 2 | 2023 | 40 | 0.100 |
Why?
|
| Software | 3 | 2019 | 37 | 0.100 |
Why?
|
| Seasons | 3 | 2021 | 154 | 0.100 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2012 | 23 | 0.100 |
Why?
|
| Hygiene | 2 | 2023 | 23 | 0.100 |
Why?
|
| Fear | 2 | 2022 | 11 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2020 | 656 | 0.100 |
Why?
|
| Ghana | 3 | 2019 | 67 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 253 | 0.100 |
Why?
|
| Emotions | 2 | 2023 | 18 | 0.100 |
Why?
|
| Waist Circumference | 3 | 2018 | 60 | 0.100 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 3 | 2020 | 42 | 0.100 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 43 | 0.100 |
Why?
|
| Water | 2 | 2022 | 22 | 0.100 |
Why?
|
| Mathematical Computing | 1 | 2011 | 2 | 0.100 |
Why?
|
| Maternal Age | 4 | 2015 | 22 | 0.100 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2011 | 14 | 0.090 |
Why?
|
| Seroepidemiologic Studies | 2 | 2022 | 109 | 0.090 |
Why?
|
| Heart Failure | 3 | 1996 | 38 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 132 | 0.090 |
Why?
|
| Death, Sudden | 1 | 2011 | 2 | 0.090 |
Why?
|
| Complementary Therapies | 1 | 2011 | 3 | 0.090 |
Why?
|
| Celiac Disease | 1 | 2011 | 8 | 0.090 |
Why?
|
| Risk | 3 | 2016 | 87 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2017 | 90 | 0.090 |
Why?
|
| Terminal Care | 1 | 2011 | 35 | 0.090 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 19 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2014 | 480 | 0.090 |
Why?
|
| Physician's Role | 1 | 2010 | 8 | 0.090 |
Why?
|
| Asia | 3 | 2014 | 72 | 0.090 |
Why?
|
| Biomarkers | 2 | 2023 | 327 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2014 | 64 | 0.090 |
Why?
|
| Memory, Short-Term | 2 | 2021 | 7 | 0.090 |
Why?
|
| Pneumonia | 3 | 1996 | 131 | 0.090 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2023 | 28 | 0.090 |
Why?
|
| Prejudice | 1 | 2009 | 8 | 0.090 |
Why?
|
| C-Reactive Protein | 2 | 2023 | 96 | 0.090 |
Why?
|
| Refugees | 2 | 2013 | 10 | 0.090 |
Why?
|
| Growth Disorders | 1 | 2010 | 56 | 0.080 |
Why?
|
| Uganda | 2 | 2024 | 197 | 0.080 |
Why?
|
| Long-Term Care | 2 | 2020 | 13 | 0.080 |
Why?
|
| Feces | 2 | 2020 | 30 | 0.080 |
Why?
|
| Genotype | 2 | 2021 | 442 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 188 | 0.080 |
Why?
|
| Australia | 2 | 2019 | 48 | 0.070 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2007 | 2 | 0.070 |
Why?
|
| Social Security | 1 | 2007 | 3 | 0.070 |
Why?
|
| Vietnam | 3 | 2016 | 13 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2019 | 107 | 0.070 |
Why?
|
| Self-Examination | 1 | 2007 | 1 | 0.070 |
Why?
|
| Joints | 1 | 2007 | 9 | 0.070 |
Why?
|
| Hospitals, Teaching | 3 | 1997 | 21 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2007 | 26 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2007 | 22 | 0.070 |
Why?
|
| Contraception Behavior | 1 | 2007 | 54 | 0.070 |
Why?
|
| Family Planning Services | 1 | 2007 | 46 | 0.070 |
Why?
|
| Multilevel Analysis | 2 | 2019 | 8 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2006 | 17 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 21 | 0.070 |
Why?
|
| Accidents | 2 | 2013 | 5 | 0.070 |
Why?
|
| Breast Feeding | 1 | 2007 | 120 | 0.070 |
Why?
|
| Hip Fractures | 2 | 1995 | 7 | 0.060 |
Why?
|
| Prenatal Care | 2 | 2023 | 147 | 0.060 |
Why?
|
| Patient Admission | 3 | 1996 | 11 | 0.060 |
Why?
|
| Telephone | 1 | 2025 | 5 | 0.060 |
Why?
|
| Waist-Hip Ratio | 2 | 2017 | 29 | 0.060 |
Why?
|
| Social Environment | 1 | 2024 | 11 | 0.060 |
Why?
|
| Africa, Eastern | 1 | 2024 | 17 | 0.060 |
Why?
|
| Models, Biological | 2 | 2015 | 77 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 260 | 0.060 |
Why?
|
| Marital Status | 2 | 2014 | 11 | 0.060 |
Why?
|
| Motor Activity | 2 | 2015 | 46 | 0.060 |
Why?
|
| Africa, Southern | 1 | 2024 | 91 | 0.060 |
Why?
|
| Survival Rate | 2 | 2019 | 96 | 0.060 |
Why?
|
| Vital Statistics | 2 | 2014 | 10 | 0.060 |
Why?
|
| Zimbabwe | 1 | 2024 | 120 | 0.060 |
Why?
|
| Culture | 2 | 2018 | 23 | 0.060 |
Why?
|
| Employment | 1 | 2024 | 27 | 0.060 |
Why?
|
| Bacterial Load | 2 | 2014 | 32 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 1 | 2023 | 2 | 0.060 |
Why?
|
| Religion | 1 | 2023 | 1 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2015 | 889 | 0.050 |
Why?
|
| Child Health | 1 | 2023 | 77 | 0.050 |
Why?
|
| Feedback | 1 | 2023 | 6 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2022 | 17 | 0.050 |
Why?
|
| Financial Statements | 1 | 2022 | 2 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2023 | 42 | 0.050 |
Why?
|
| Peer Group | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 24 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2023 | 85 | 0.050 |
Why?
|
| Bordetella pertussis | 1 | 2023 | 29 | 0.050 |
Why?
|
| Toilet Facilities | 1 | 2022 | 1 | 0.050 |
Why?
|
| Water Supply | 1 | 2022 | 10 | 0.050 |
Why?
|
| Metagenomics | 1 | 2022 | 13 | 0.050 |
Why?
|
| Administrative Personnel | 1 | 2022 | 17 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 46 | 0.050 |
Why?
|
| Social Responsibility | 1 | 2022 | 12 | 0.050 |
Why?
|
| Zambia | 1 | 2022 | 115 | 0.050 |
Why?
|
| Men | 1 | 2021 | 15 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 101 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 53 | 0.050 |
Why?
|
| Cooking | 1 | 2021 | 7 | 0.050 |
Why?
|
| Community Health Workers | 1 | 2022 | 66 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2001 | 9 | 0.050 |
Why?
|
| Stakeholder Participation | 1 | 2021 | 9 | 0.050 |
Why?
|
| Mastectomy | 1 | 2001 | 10 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2000 | 13 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 18 | 0.050 |
Why?
|
| HIV Seronegativity | 1 | 2020 | 52 | 0.040 |
Why?
|
| Bacteria | 1 | 2020 | 47 | 0.040 |
Why?
|
| Seizures | 1 | 2020 | 20 | 0.040 |
Why?
|
| Social Perception | 1 | 2020 | 7 | 0.040 |
Why?
|
| Accelerometry | 1 | 2020 | 19 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 38 | 0.040 |
Why?
|
| Psychology, Adolescent | 1 | 2020 | 1 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2020 | 9 | 0.040 |
Why?
|
| Serotyping | 1 | 2020 | 66 | 0.040 |
Why?
|
| Endemic Diseases | 1 | 2019 | 15 | 0.040 |
Why?
|
| Reproductive Health | 1 | 2020 | 51 | 0.040 |
Why?
|
| Fever | 1 | 2019 | 26 | 0.040 |
Why?
|
| Child, Hospitalized | 1 | 2019 | 26 | 0.040 |
Why?
|
| Health Facilities | 1 | 2020 | 40 | 0.040 |
Why?
|
| Contraception | 1 | 2020 | 90 | 0.040 |
Why?
|
| Population Density | 1 | 1999 | 13 | 0.040 |
Why?
|
| Medicaid | 2 | 1997 | 2 | 0.040 |
Why?
|
| Burkina Faso | 1 | 2019 | 29 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 32 | 0.040 |
Why?
|
| Afghanistan | 1 | 2019 | 3 | 0.040 |
Why?
|
| Uncertainty | 1 | 2019 | 7 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2019 | 14 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 15 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 14 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2019 | 6 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2017 | 133 | 0.040 |
Why?
|
| Emtricitabine | 1 | 2019 | 78 | 0.040 |
Why?
|
| Lamivudine | 1 | 2019 | 89 | 0.040 |
Why?
|
| Blood | 1 | 2019 | 51 | 0.040 |
Why?
|
| Plasma | 1 | 2018 | 39 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 38 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 80 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 20 | 0.040 |
Why?
|
| Women's Health | 1 | 2018 | 41 | 0.040 |
Why?
|
| Viremia | 1 | 2018 | 66 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 47 | 0.040 |
Why?
|
| Length of Stay | 2 | 1995 | 43 | 0.040 |
Why?
|
| Nutrition Assessment | 1 | 2018 | 12 | 0.040 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 9 | 0.040 |
Why?
|
| Environment | 1 | 2018 | 22 | 0.040 |
Why?
|
| Women | 1 | 2017 | 12 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 150 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 151 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 11 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 1997 | 8 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 5 | 0.040 |
Why?
|
| Exercise Test | 1 | 2017 | 13 | 0.040 |
Why?
|
| Disclosure | 1 | 2017 | 25 | 0.040 |
Why?
|
| Poverty Areas | 1 | 2017 | 20 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 1997 | 5 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 3 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2017 | 5 | 0.040 |
Why?
|
| Enterovirus | 1 | 2017 | 9 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 5 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 33 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 2019 | 247 | 0.030 |
Why?
|
| Cancer Survivors | 1 | 2017 | 3 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 17 | 0.030 |
Why?
|
| Cross Infection | 1 | 1997 | 52 | 0.030 |
Why?
|
| Glycated Hemoglobin A | 1 | 2017 | 24 | 0.030 |
Why?
|
| Patient Discharge | 1 | 1997 | 27 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 27 | 0.030 |
Why?
|
| Cognitive Reserve | 1 | 2016 | 2 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2017 | 29 | 0.030 |
Why?
|
| Hospital Information Systems | 1 | 1996 | 1 | 0.030 |
Why?
|
| Mediastinum | 1 | 1996 | 1 | 0.030 |
Why?
|
| Forms and Records Control | 1 | 1996 | 3 | 0.030 |
Why?
|
| Pleura | 1 | 1996 | 3 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 1996 | 2 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 81 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 1996 | 11 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 43 | 0.030 |
Why?
|
| Bangladesh | 1 | 2016 | 17 | 0.030 |
Why?
|
| Bone and Bones | 1 | 1996 | 38 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 13 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2016 | 6 | 0.030 |
Why?
|
| Puberty | 1 | 2016 | 22 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 91 | 0.030 |
Why?
|
| Microscopy | 1 | 2016 | 21 | 0.030 |
Why?
|
| Cross Protection | 1 | 2016 | 4 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 64 | 0.030 |
Why?
|
| Serogroup | 1 | 2017 | 150 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2016 | 30 | 0.030 |
Why?
|
| Paramyxoviridae Infections | 1 | 2016 | 27 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2015 | 6 | 0.030 |
Why?
|
| Epidemiology | 1 | 1995 | 4 | 0.030 |
Why?
|
| Personal Autonomy | 1 | 1995 | 6 | 0.030 |
Why?
|
| Reference Standards | 2 | 2012 | 29 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 150 | 0.030 |
Why?
|
| Insurance, Health | 1 | 1995 | 16 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 1995 | 26 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2010 | 31 | 0.030 |
Why?
|
| Child Behavior | 1 | 2015 | 11 | 0.030 |
Why?
|
| Outpatients | 1 | 2015 | 38 | 0.030 |
Why?
|
| Suburban Population | 1 | 2014 | 9 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 11 | 0.030 |
Why?
|
| Prospective Payment System | 2 | 1992 | 2 | 0.030 |
Why?
|
| England | 1 | 2014 | 15 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 22 | 0.030 |
Why?
|
| Health | 1 | 2014 | 11 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2014 | 21 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 42 | 0.030 |
Why?
|
| Federal Government | 1 | 1994 | 2 | 0.030 |
Why?
|
| Urbanization | 1 | 2014 | 11 | 0.030 |
Why?
|
| Food Supply | 1 | 2014 | 29 | 0.030 |
Why?
|
| Program Development | 1 | 2014 | 32 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2013 | 9 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2013 | 13 | 0.030 |
Why?
|
| Achievement | 1 | 2013 | 1 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 284 | 0.030 |
Why?
|
| Age of Onset | 1 | 2013 | 32 | 0.030 |
Why?
|
| Brain | 1 | 2013 | 53 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2014 | 171 | 0.030 |
Why?
|
| Unemployment | 1 | 2013 | 10 | 0.030 |
Why?
|
| Oropharynx | 1 | 2012 | 17 | 0.030 |
Why?
|
| Fees, Medical | 1 | 1992 | 2 | 0.030 |
Why?
|
| Health Maintenance Organizations | 1 | 1992 | 4 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 2013 | 81 | 0.030 |
Why?
|
| International Cooperation | 1 | 2013 | 50 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 5 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 370 | 0.030 |
Why?
|
| Professional Review Organizations | 1 | 1992 | 1 | 0.030 |
Why?
|
| Morbidity | 1 | 2011 | 37 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2011 | 6 | 0.020 |
Why?
|
| Indonesia | 1 | 2010 | 7 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2010 | 11 | 0.020 |
Why?
|
| Ethiopia | 1 | 2010 | 18 | 0.020 |
Why?
|
| Malaria | 1 | 2013 | 213 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 22 | 0.020 |
Why?
|
| Gloves, Surgical | 1 | 1990 | 1 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 1990 | 4 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 1990 | 40 | 0.020 |
Why?
|
| Attitude to Death | 1 | 2007 | 6 | 0.020 |
Why?
|
| Coroners and Medical Examiners | 1 | 2006 | 1 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 2 | 1997 | 2 | 0.010 |
Why?
|
| Cough | 1 | 2004 | 14 | 0.010 |
Why?
|
| Censuses | 1 | 1999 | 2 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1997 | 66 | 0.010 |
Why?
|
| Medical Audit | 1 | 1992 | 26 | 0.010 |
Why?
|
| Hospital Records | 1 | 1992 | 1 | 0.010 |
Why?
|
| Random Allocation | 1 | 1992 | 23 | 0.010 |
Why?
|
| Algorithms | 1 | 1992 | 106 | 0.010 |
Why?
|
| California | 1 | 1990 | 9 | 0.010 |
Why?
|